Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine

B. E. Johnson, J. D. Bridges, M. Sobczeck, J. Gray, R. I. Linnoila, A. F. Gazdar, L. Hankins, S. M. Steinberg, M. Edison, J. N. Frame, H. Pass, J. Nesbitt, D. Holden, J. L. Mulshine, E. Glatstein, D. C. Ihde

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Fingerprint

Dive into the research topics of 'Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine'. Together they form a unique fingerprint.

Medicine & Life Sciences